Risperidone-Induced Obesity in Children and Adolescents With Autism Spectrum Disorder: Genetic and Clinical Risk Factors

Aims: Obesity is a significant problem for patients taking atypical antipsychotics. There were two aims of our study. The first aim was to compare the prevalence of overweight and obesity between children and adolescents with autism spectrum disorder (ASD) treated with risperidone with the general p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Vanwong, Natchaya, Ngamsamut, Nattawat, Nuntamool, Nopphadol, Hongkaew, Yaowaluck, Sukprasong, Rattanaporn, Puangpetch, Apichaya, Limsila, Penkhae, Sukasem, Chonlaphat
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677569/
https://ncbi.nlm.nih.gov/pubmed/33240086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.565074
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars